首页> 外文期刊>Microbiology and Immunology >Mediterranean fever gene mutations: correlation with cytotoxic T-lymphocyte-associated antigen 4 gene polymorphism
【24h】

Mediterranean fever gene mutations: correlation with cytotoxic T-lymphocyte-associated antigen 4 gene polymorphism

机译:地中海发热基因突变:与细胞毒性T淋巴细胞相关抗原4基因多态性的相关性

获取原文
获取原文并翻译 | 示例
       

摘要

Mutations in the Mediterranean fever (MEFV) gene lead to familial Mediterranean fever (FMF), a pro-inflammatory state characterized by outbursts of inflammatory cytokines. The aims of this study were to identify the common mutations of MEFV gene in Egyptian patients with FMF, to study cytotoxic T lymphocyte associated antigen 4 (CTLA-4) gene polymorphism and to evaluate correlations between CTLA4-1661 polymorphisms and MEFV mutations and clinical symptoms. Four hundred and twenty-four patients with clinical pictures suspicious of FMF were enrolled in this study. Mutations in MEFV gene were confirmed by reversed hybridization. Patients with homozygous and compound heterozygous mutations and 120 healthy controls were investigated for polymorphism of -1661 CTLA4 gene and the findings correlated with disease incidence and clinical symptoms of the disease. Ninety-seven patients had single heterozygous mutations and 78 had compound heterozygous or homozygous MEFV gene mutations. M694I/V726A was the most common genotype (14.1%), followed by homozygous M694I. There was no statistically significant difference between patients and controls in incidence of -1661A/G single nucleotide polymorphism CTLA4 (P=0.189), nor any significant correlation with any of the clinical symptoms of FMF and MEFV gene mutations.
机译:地中海发烧(MEFV)基因的突变导致家族性地中海发热(FMF),一种促炎症的促炎状态,其爆发炎症细胞因子。本研究的目的是鉴定埃及FMF患者MEFV基因的常见突变,研究细胞毒性T淋巴细胞相关抗原4(CTLA-4)基因多态性,并评估CTLA4-1661多态性与MEFV突变之间的相关性和临床症状。四百二十四名患有FMF的临床图片的临床图片均已注册本研究。通过反转的杂交证实MEFV基因中的突变。研究了纯合的杂合突变和120例健康对照,用于-1661 CTLA4基因的多态性,以及与疾病的疾病发病率相关和疾病的临床症状相关。九十七名患者具有单一的杂合突变,78种具有化合物杂合或纯合的MEFV基因突变。 M694i / V726a是最常见的基因型(14.1%),其次是纯合M694i。在1661A / g的发病率 - 1661A / g的单核苷酸多态性CTLA4(P = 0.189)的患者中没有统计学显着差异,也没有与FMF和MEFV基因突变的任何临床症状的任何显着相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号